A PYMNTS Company

US: Longstop date on healthcare merger extended due to regulator

By  |  March 10, 2015

An antitrust inquiry has delayed Steris’ effort to buy Synergy Health for $1.9 billion.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The Federal Trade Commission issued a so-called “second request” seeking more information about the deal in January.

    Because of the inquiry, it will be at least another two months before Steris shareholders vote on whether the Mentor-based medical sterilization company should close what would be the biggest deal in the company’s history.

    Steris and Synergy, a British company that provides sterilization services, originally aimed to close the deal in March, but now they’re aiming for June.

     

    Full Content: Nasdaq

     

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.